Those Halloween Lenses Need a Prescription in America and a Notified Body in Europe. On 1 January, Europe's Grace Period Starts Closing.

VisioncarePro by

Every autumn, eyewear stores add a coloured-lens range for Halloween and cosplay. They are cheap, they sell fast, and they have no medical purpose whatsoever. That last fact is the one that misleads people. Both the United States and the European Union regulate non-corrective decorative contact lenses as medical devices — and they do it in completely different places in your supply chain.

The short version: in America, the rule bites at your checkout. You may not sell a pair without a prescription you have obtained or verified. In Europe, the rule bites at the factory. There is no EU-wide prescription requirement at all, but the lens itself has to be a conformity-assessed, CE-marked device — and the transitional arrangement that many of these products still rely on narrows on 1 January 2027.

Getting one of those right does nothing for the other. If you sell into both markets, you need both.

The American rule is one sentence long, and it does all the work

On 9 November 2005, Public Law 109-96 added section 520(n) to the Federal Food, Drug, and Cosmetic Act. The text, now at 21 U.S.C. § 360j(n)(1), reads in full:

"All contact lenses shall be deemed to be devices under section 321(h) of this title."

Read it again and notice what is not in it. It does not say "corrective". It does not say "prescription". It does not mention decorative lenses, cosplay lenses, circle lenses or costume lenses. It says all, and the breadth of the provision lives entirely in that word.

Congress then added § 360j(n)(2) to stop the deeming from leaking: the fact that a contact lens is a device "shall not be construed as bearing on or being relevant to the question of whether any product other than a contact lens is a device … or a drug". So the clause is wide within its subject and sealed at its edges. That is deliberate drafting, and it is why the argument "but mine are just a costume accessory" has never worked.

"Decorative" is not a category the FDA recognises as an exit

The FDA's guidance Decorative, Non-corrective Contact Lenses, issued on 24 November 2006, sets out the consequences. It records that section 520(n) was added "to establish that all contact lenses are devices under section 201(h) of the Act", and then applies the ordinary device framework to them:

  • Premarket authorisation. All contact lenses "must be the subject of a cleared premarket notification (510(k)) or an approved premarket approval application (PMA) before they may be legally marketed."
  • Prescription status. "All currently approved or cleared decorative contact lenses are legally marketed only as prescription devices (21 CFR 801.109)." The guidance says they should not be marketed or made available to consumers as an over-the-counter item.
  • Consequences without clearance. Lenses without premarket authorisation are adulterated under section 501(f)(1)(B) of the Act (21 U.S.C. § 351(f)(1)(B)) and misbranded under section 502(o) (21 U.S.C. § 352(o)).
  • At the border. Non-compliant imported lenses are subject to detention without physical examination under Import Alert 89-08.

That last point is the one that catches drop-shipped and direct-from-overseas ranges. A product that never reaches your warehouse can still be the reason a shipment is held, and the detention mechanism does not require anyone to examine the goods first.

FDA guidance documents are not themselves binding law, and this one says so in the usual terms. The binding parts are the statute, the clearance requirement and the prescription-device labelling regulation it points at. But the guidance is the agency's stated position, it has stood for twenty years, and no seller should plan around the hope that the FDA has quietly changed its mind.

The FDA's own consumer page, last updated on 22 October 2024, puts the same point in plainer words: "All contact lenses must be prescribed by a doctor, including decorative lenses," and "Anyone selling you contact lenses must get your prescription and verify it with your doctor … If they don't ask for this information they are breaking federal law."

The FTC rule that does not say it covers you — and covers you

The operative selling duty is not in the FDA's rules. It is in the Federal Trade Commission's Contact Lens Rule, 16 C.F.R. Part 315, which implements the Fairness to Contact Lens Consumers Act.

Now look at how the Rule defines its own subject matter. 16 C.F.R. § 315.2 defines a contact lens as:

"any contact lens for which State or Federal law requires a prescription."

That definition tells you nothing on its own. It is a pointer. Whether your Halloween range is inside the Contact Lens Rule is not a question you can answer by reading the Contact Lens Rule — you answer it by reading the FDCA and the FDA's classification, and then coming back. Because the FDA treats every cleared decorative lens as a prescription device, the FTC's definition closes around them, and Part 315 applies in full.

What Part 315 then requires of a seller, under § 315.5, is concrete:

  • You may sell only in accordance with a prescription that is presented to you by the patient or prescriber, or that you have verified by direct communication with the prescriber.
  • Your verification request has to carry a specified set of information — patient name and address, the lens specifications, quantity, the date and time of the request, and your own contact details, including Saturday hours if you have them.
  • A prescription is verified if the prescriber confirms it, corrects it, or fails to communicate with you within eight business hours of receiving the information.
  • If you verify by automated telephone call, the entire call must be recorded, identified as a verification request, delivered slowly and clearly, and made repeatable.
  • You must keep the records of these communications for three years.

That eight-business-hour window is the part most stores build their operations around, and it is also the part most often built wrong: the clock is a floor for the prescriber's silence, not a licence to ship on hour one.

If you already run a prescription eyewear operation, you have most of this. The mistake is assuming the coloured range sits outside it because nothing about the product is corrective. It does not. The same reasoning is why an AI checkout that skips your prescription form does not skip your obligation.

Europe starts somewhere else entirely

The EU's Medical Device Regulation, Regulation (EU) 2017/745, does not deem contact lenses to be devices. It does something stranger and, once you see it, more elegant: it has an annex of products that are admittedly not medical devices, and it applies to them anyway.

Annex XVI, headed "list of groups of products without an intended medical purpose", opens at point 1 with:

"Contact lenses or other items intended to be introduced into or onto the eye."

The switch that turns this into law is Article 1(2). The MDR applies to the Annex XVI groups from the date of application of the common specifications adopted for them under Article 9. Until those specifications applied, an Annex XVI product was not an MDR device. This is worth pausing on: the MDR's scope over your coloured lenses was set by a different instrument arriving later.

That instrument is Commission Implementing Regulation (EU) 2022/2346 of 1 December 2022. Annex I lays down common specifications for all the Annex XVI groups; Annex II is the contact-lens-specific set, covering risk management, materials and biocompatibility, sterilisation, packaging and user-facing hazards including hygiene and contra-indications. Article 3 gives the date: it applies from 22 June 2023.

So the answer to "when did plano coloured lenses become regulated devices in Europe?" is 22 June 2023 — not 26 May 2021 when the MDR itself started to apply, and not 2017.

The date that matters to your Q4 supplier list: 1 January 2027

Article 2 of 2022/2346 is the transitional regime, and it was rewritten before it ever ran, by Commission Implementing Regulation (EU) 2023/1194 of 20 June 2023, which applies from 22 June 2023. What follows is the amended text — the version that governs.

A product that was lawfully on the market before 22 June 2023, and whose design and intended purpose have not significantly changed, may continue to be placed on the market:

  • Until 31 December 2028, where no clinical investigation is required — but from 1 January 2027 only where a written agreement for the performance of the conformity assessment has been signed by the notified body and the manufacturer (Article 2(2)).
  • Until 31 December 2029, where a clinical investigation is required, with its own staged conditions — a notification by 22 December 2024, an investigation started by 31 December 2027, and from 1 January 2028 the same signed written agreement with a notified body (Article 2(1)).

Read commercially, that means the deadline arriving first is not a paperwork date for you. It is a date on which some of your suppliers stop being able to ship into the EU, because they never signed with a notified body. Notified body capacity for Annex XVI products is limited, and a written agreement is not something a manufacturer arranges in a fortnight in December.

If you sell coloured lenses into the EU, the useful question to put to every supplier this quarter is not "are you CE marked?" It is: "Which route are you on, and if it is the Article 2 transitional route, do you have a signed notified body agreement?"

The two systems, side by side

United States European Union
Where the rule bites The sale — your checkout The placing on the market — the factory
How plano lenses got in A deeming clause: "all contact lenses" (21 U.S.C. § 360j(n)(1)) An annex of products without a medical purpose (MDR Annex XVI, point 1)
Date it started 9 November 2005 22 June 2023
Prescription required? Yes — prescription devices; seller must present or verify Not by EU law. A matter for national rules
Premarket step 510(k) clearance or PMA approval Conformity assessment and CE marking; common specifications in Reg. (EU) 2022/2346
Who carries the duty The seller, at the point of sale The manufacturer, with importer and distributor duties downstream
Next live date None pending — the regime is settled 1 January 2027: signed notified body agreement required to stay on the transitional route
Failure mode Adulterated and misbranded goods; import detention under Import Alert 89-08 A non-conforming device on your listing, with the distributor and importer obligations that follow

The thing that surprises most merchants

There is no EU-wide prescription requirement for contact lenses. The MDR is a product regulation: it asks whether the lens is safe, conformity-assessed and correctly marked. It does not tell you who may buy one.

Whether a fitting, an eye examination or a prescription is required before supply is left to the law of each Member State, and those rules are not uniform. We are not going to tell you what any particular country requires, because that is a national-law question that deserves a local answer rather than a confident paragraph in a blog post.

What we will say is this: the absence of an EU prescription rule is not permission. It means the control has been placed somewhere else — on the product, before it ever reaches you — and that a US store expanding into Europe cannot simply port its verification workflow across and consider itself done. The workflow is not what Europe is asking about.

Where this sits next to the rest of your device obligations

If you are selling contact lenses into the EU, the MDR reaches you in more than one place at once:

What we are deliberately not saying

Several things here are genuinely unsettled, and we would rather flag them than paper over them.

  • Which national rules require a prescription or fitting in the EU. Not researched here, and it varies.
  • Whether a given coloured lens on the market today is on the Article 2 transitional route or fully conformity-assessed. Only the manufacturer can tell you, and the answer decides whether 1 January 2027 is your problem.
  • How Annex II of Reg. (EU) 2022/2346 treats lenses containing antennas or other active components. The common specifications draw a line there; smart and connected lenses are a different conversation.
  • Whether every decorative lens sold in the US today actually holds a 510(k). Many do not. That is a supplier-diligence question, not a legal-interpretation one.
  • State-level US requirements. The FTC definition points at "State or Federal law", and states can add to the federal floor.

Seven things to do before the range goes live

  1. Find the coloured and costume lenses in your catalogue. They are often tagged as accessories rather than as lenses, which is exactly how they slip past a compliance review.
  2. Put them behind the same prescription gate as your corrective lenses for US orders. Presented or verified — there is no third option.
  3. Check your verification flow against § 315.5: the required information in the request, the eight-business-hour window treated as a floor, recorded automated calls, and three-year record retention.
  4. Ask every supplier for the 510(k) or PMA number for each SKU you list into the US, and keep the answer.
  5. Ask every EU supplier which MDR route they are on, and whether a written notified body agreement is signed. Do this before the 1 January 2027 cliff, not after.
  6. Check whether you are an importer or a distributor for EU purposes, because the registration duty follows that answer.
  7. Fix the product copy. "No prescription needed" on a decorative lens listing is not a selling point; in the US it is close to an admission.

Questions we get asked

They have no corrective power at all. Does that really make them a medical device?
In the US, yes — the statute deems all contact lenses to be devices and does not carve out plano lenses. In the EU, yes — through Annex XVI, which exists precisely for products that have no medical purpose.

We only sell them for Halloween, a few weeks a year.
Neither regime has a seasonal or a low-volume exemption. Nothing in what we read creates one, which is a finding from reading the provisions rather than proof that no exemption exists anywhere.

Our supplier says they are CE marked. Is that the end of it?
No. CE marking is a claim about the product. It does not tell you whether the manufacturer is relying on the Article 2 transitional route, which is the part that changes on 1 January 2027.

We are a US store shipping to EU customers occasionally. Which rules apply?
Potentially both, and for different reasons: the US rule because you are the seller, the EU rules because the product is being placed on the EU market. Work out your role in the EU chain first.

Is 1 January 2027 a deadline for us?
Not directly. It is a deadline for manufacturers, which reaches you as a supply problem and as a listing you may no longer be able to sell lawfully into the EU.

The pattern, if you have been reading along

Most of what we write about comes down to a single question: where does the line get drawn? Usually it is drawn by what the object is, or by what your store did to it, or by where the checkout renders, or by whose hands it passed through, or by which medium an advertisement is delivered in.

Decorative contact lenses add another: the line is drawn by where in the chain the regulator chose to intervene. Same product, same risk to the same eye, and two of the world's largest markets place their control point at opposite ends — one at the moment of sale, one at the moment of manufacture. A store that satisfies one has done nothing towards the other, and there is no single workflow that satisfies both by accident.

There is a second, quieter lesson in here, and it turned up on both sides independently. The FTC's Contact Lens Rule defines its own scope by pointing at other law. The MDR's Article 1(2) makes its own application to Annex XVI conditional on a later instrument. In both cases you cannot answer "does this apply to me?" from the instrument in front of you. It is worth asking, every time: does this rule define its own scope, or borrow it?

General information, not legal advice. This post describes our reading of published legislation, regulations and agency guidance as at 24 September 2026, and it is general information rather than legal or regulatory advice on your products. FDA guidance documents do not create legally enforceable responsibilities. National rules within the EU on the supply of contact lenses are not covered here. Nothing in this post asserts anything about VisioncarePro's own compliance status, and you should take advice on your specific catalogue and markets.

Sources: 21 U.S.C. § 360j(n) (FDCA § 520(n), added by Public Law 109-96, 9 November 2005), via the US House Office of the Law Revision Counsel · FDA, Decorative, Non-corrective Contact Lenses — Guidance for Industry, FDA Staff, Eye Care Professionals, and Consumers, issued 24 November 2006 · FDA, Decorative Contact Lenses for Halloween and More, last updated 22 October 2024 · FTC Contact Lens Rule, 16 C.F.R. Part 315, §§ 315.1, 315.2, 315.3 and 315.5, via the Electronic Code of Federal Regulations · Regulation (EU) 2017/745 (MDR), Article 1(1)–(2) and Annex XVI point 1 · Commission Implementing Regulation (EU) 2022/2346 of 1 December 2022, Articles 1, 2 and 3 and Annexes I and II, consolidated text as at 22 June 2023 · Commission Implementing Regulation (EU) 2023/1194 of 20 June 2023 amending the transitional provisions of Implementing Regulation (EU) 2022/2346 · FDA Import Alert 89-08.

RuffRuff Apps RuffRuff Apps by Tsun